Quadrant Biosciences Inc. e phatlalalitse kajeno hore United States Patent le Trademark Office (USPTO) e fane ka khampani le balekane ba eona, SUNY Research Foundation le Penn State Research Foundation, US Patent No. 11,242,563 (Analysis of Autism Spectrum Disorder). Patent e akaretsa motheo oa mahlale bakeng sa nts'etsopele ea thuso ea tlhahlobo ea autism e thehiloeng ho mathe, e ka khethollang batho ba nang le autism ho batho ba nang le tsoelo-pele e tloaelehileng kapa tieho ea tsoelo-pele ka ho lekanya maemo a microRNA (miRNA) le microbiome mathe. Quadrant Biosciences, k'hamphani ea Life Science e Syracuse, New York, e sebelisa tatellano ea moloko o latelang le AI ho hlahisa tlhahlobo ea limolek'hule tse thehiloeng ho RNA bakeng sa maemo a fapaneng a bongaka.
"Ho ntšoa ha tumello ea molao ea US bakeng sa mosebetsi oa rona oa nts'etsopele ea thuso ea tlhahlobo ea mathe bakeng sa autism ke kananelo e hlakileng ea mokhoa o mocha oo re o hlahisitseng," ho boletse Frank Middleton, PhD, Moprofesa oa SUNY Upstate Medical. Univesithi le e mong oa bafuputsi ba ka sehloohong ba entseng lipatlisiso tse nang le tokelo ea molao. "Ho tsepamisa maikutlo ha rona ho sebeliseng mokhoa oa multiomic o kopanyang likarolo tsa taolo tsa RNA ho tsoa ho motho ea amohelang batho hammoho le microbiome ea molomo ho fane ka temohisiso e kholo ka lefu la autism spectrum."
Dr. Steve Hicks, MD, PhD ho tloha Penn State College of Medicine, moqapi e mong ea ka sehloohong oa patent, o hlalositse bohlokoa ba eona ba kliniki. "Re tšepa hore sesebelisoa sena sa limolek'hule se tla ntlafatsa bokhoni ba baoki ba ho khetholla bana ba nang le autism ho tsoa ho lithaka tse nang le tieho ea tsoelo-pele e sa amaneng le autistic, e leng ho nolofalletsang ho hlahlojoa pele le ho qala pele ho phekolo ea boitšoaro. Ho feta moo, o ile a tsoela pele, "nako ena ea bohlokoa e tiisa boqapi bo entsoeng lipatlisisong tsa Quadrant Biosciences 'me e ntšetsa pele sepheo sa rona se kopaneng sa ho ntlafatsa tlhokomelo ea bongaka bakeng sa bana ba nang le autism spectrum disorder."
"Re thabetse hore USPTO e fane ka tumello ea rona bakeng sa mosebetsi ona oa motheo," ho boletse Rich Uhlig, Mothehi le CEO oa Quadrant Biosciences. "Sena se ts'ehetsa lilemo tsa rona tsa boiteko bo matla ba R&D ba ho khantša lintlha tsa epigenetic tse amanang le autism, le ho hlahisa li-biomarker tse ncha tsa tlhahlobo ea mafu ho sebetsana le tlhoko e potlakileng ea ho khutsufatsa nako e telele ea tlhahlobo ea autism bakeng sa batsoali le bahlokomeli."
